Plasma Anti-FXa Concentration After Continuous Intravenous Infusion and Subcutaneous Dosing of Enoxaparin for Thromboprophylaxis in Critically Ill Patients
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Venous thromboembolism
- Focus Pharmacokinetics
- 26 Oct 2017 Status changed from recruiting to completed.
- 24 Jan 2013 New trial record